ENLIVEN: Pegozafermin Could Reduce Improve Fibrosis in NASH
Pegozafermin was associated with improvements in fibrosis and could contribute to a resolution of NASH, according to the results of the phase 2b ENLIVEN trial.
Stay updated with breaking news from Scientific Session. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pegozafermin was associated with improvements in fibrosis and could contribute to a resolution of NASH, according to the results of the phase 2b ENLIVEN trial.
A tablet form of semaglutide for weight loss showed positive results in phase 3 clinical trials, researchers announced at the American Diabetes Association (ADA) Scientific Session in Los Angeles, California.
Fairfax, VA (PRWEB) June 14, 2023 -- Rob S.B. Beanlands, MD, MASNC, deputy director general of the University of Ottawa Heart Institute and internationally
/PRNewswire/ -- AEYE Health, a leading provider of AI-based diagnostic screening solutions, is thrilled to announce the appointment of Guillermo Umpierrez, MD,...
The 2023 Society of Breast Imaging (SBI) Breast Imaging Symposium, SBI 2023, is set for May 4-7 at the Gaylord National Resort & Convention Center in National Harbor, Maryland. The in-person-only event theme, “Advancing What’s Possible: Better Every Day,” underscores the focus of the program schedule, as symposium planners promote the opportunities to explore ways to advance patient care, including those underserved, enhance their practice and boost both careers and self-care.